Thailand is preparing to refocus its cannabis industry toward medical use, as authorities respond to a decline in the number of cannabis shops and seek to reinforce regulatory clarity within the sector.

Officials have indicated that the move is part of a broader effort to strengthen oversight and ensure that cannabis-related businesses operate within a clearly defined legal framework.

The shift toward medical use is expected to prioritize patient access, quality standards and professional supervision.

The number of cannabis outlets has fallen in recent months, reflecting tighter enforcement measures and evolving market conditions.

Authorities view the transition as an opportunity to stabilize the industry and align it more closely with public health objectives.

Thailand has been a regional pioneer in cannabis reform, with earlier steps opening the market and encouraging innovation.

The latest policy direction is designed to build on that foundation while addressing challenges associated with rapid expansion and uneven compliance.

Industry participants are expected to adapt to the new requirements, with greater emphasis on licensing, medical oversight and product regulation.

The approach is intended to create a more sustainable and credible sector that can support long-term growth.

The shift underscores Thailand’s commitment to responsible policy development, balancing economic opportunity with public health considerations as it continues to shape the future of its cannabis industry.